Skip to content

Author

Yun-Peng Hu

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway.

Aliflorin suppresses BC progression by inhibiting the HINT2/NLRP3 signaling pathway, suggesting HINT2 is a viable biomarker and Al a promising therapeutic agent for BC treatment.

Yun-Peng Hu, Chen Li, Yi-Yao Cui · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.